clofarabine has been researched along with Sarcoma, Ewing in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Atasoy, S; Balaraman, K; Deniz, E; Molotkova, A; Nelson, E; Pilicer, SL; Sevim, H; Tiwari, PB; Üren, A; Wolf, C | 1 |
Çelik, H; Ceyhan, CS; Düşünceli, L; Graham, GT; Molotkova, A; Nakazawa, K; Petro, JR; Sevim, H; Toretsky, JA; Üren, A | 1 |
Allegakoen, DV; Çelik, H; Conn, EJ; Flashner, B; Gelmez, E; Han, J; Harris, BT; Hayran, M; Hour, S; Kayraklıoğlu, N; Manara, MC; Oktay, L; Petro, JR; Sciandra, M; Scotlandi, K; Tiwari, PB; Toretsky, JA; Üren, A | 1 |
3 other study(ies) available for clofarabine and Sarcoma, Ewing
Article | Year |
---|---|
Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
Topics: 12E7 Antigen; Cell Adhesion Molecules; Child; Cladribine; Clofarabine; DNA; Humans; Sarcoma, Ewing | 2023 |
Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.
Topics: 12E7 Antigen; Antimetabolites, Antineoplastic; Blotting, Western; Cell Line, Tumor; Clofarabine; CREB-Binding Protein; Humans; MAP Kinase Signaling System; Phosphorylation; Ribosomal Protein S6 Kinases, 90-kDa; Sarcoma, Ewing; Signal Transduction | 2021 |
Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.
Topics: 12E7 Antigen; A549 Cells; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Clofarabine; Female; Humans; MCF-7 Cells; Mice; Mice, SCID; Protein Binding; Sarcoma, Ewing; Signal Transduction; Small Molecule Libraries; Xenograft Model Antitumor Assays | 2018 |